PM360 2022 Innovative Strategy Commercial Acceleration from Rebound

Commercial Acceleration


Contact Person:
Meridith Rohrbaugh, Founder and CEO

Rapidly growing SaaS technology and data companies can find it challenging to develop effective marketing to life sciences manufacturers when they lack the capabilities or resources to execute programs and analyze their marketing performance. Rebound was founded in 2015 to deliver a new marketing model that enables these companies to drive faster growth and higher company valuations. This model, which Rebound calls Commercial Acceleration, offers a dramatic shift in the approach to go-to-market strategy.

The traditional approach of marketing to vendors is to provide siloed services focused on one or two components of the commercial engine, such as branding, messaging, lead generation, or sales enablement. In contrast, Rebound built an integrated process across the commercial continuum that connects and optimizes all these elements. This approach is enabled by a variety of individual “accelerators” that codify the experience of the Rebound team into standard, proven approaches for each part of the commercial process. These include a Messaging Framework Accelerator, Product Marketing Accelerator, Lead Gen Accelerator, and Events Accelerator. These are all designed to help clients achieve better results faster.

Through its approach, Rebound has helped life sciences tech and data companies:

  • Improve the way they develop their key messages and value propositions and activate them months faster than they could do on their own.
  • Extend average market visibility for product launches 6-10 times longer through a series of post-launch activities.
  • Develop internal capabilities in product marketing, pipeline development, and digital presence.

Rebound’s success has led to the company growing 893% over three years and its recognition by Inc. magazine as one of the fastest-growing private companies in America, landing at number 702 on the list.


You May Also Like

ELITE 2022 Disrupter Betty Royster of ViiV Healthcare

Betty Royster Marketing Manager, APRETUDE ViiV Healthcare Shifting the HIV Prevention Landscape Betty Royster’s ...

PM360 2022 Trailblazer Awards Specialty Pharma/Biotech Company of the Year Travere Therapeutics

Travere Therapeutics is a biopharmaceutical company dedicated to identifying, developing, and delivering life-changing therapies ...

PM360 2019 Innovative Service IntelliHealth HCP Engagement Sales Solution from Conduent

IntelliHealth HCP Engagement Sales Solution Conduent Sharon Rubin, Solutions Architect Conduent is helping ...